MYC Induced Nuclear Antigen (MINA) Peptide
MINA
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MINA products
- MINA (MYC Induced Nuclear Antigen (MINA))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MINA antibody (Catalog #: ARP39722_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MINA (MYC Induced Nuclear Antigen (MINA))
- Background
-
MINA protein is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles. MINA is also involved in cell proliferation. MINA may have a role in esophageal squamous cell carcinoma, colon cancer and lung cancer
Alias Symbols: MDIG, NO52, MINA53
Protein Interaction Partner: MINA,MYC,MINA
Protein Size: 464 - Molecular Weight
- 53 kDa
- Gene ID
- 84864
- NCBI Accession
- NM_032778, NP_116167
- UniProt
- Q96KB0
-
You are here:
